InvestSMART

VanEck Global Healthcare Leaders ETF (ASX: HLTH) - Share Price and Research

- Current share price for HLTH : $10.890

VanEck Global Healthcare Leaders ETF (HLTH) gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index.

HLTH General Information +

ASX Code HLTH
Website http://www.vaneck.com.au
Industry/Sector Asset Management & Custody Banks
Market Cap ($M) 55
HLTH Share Price $10.890
Day High $11.000
Day Low $10.880
Last Close $10.890
HLTH Share Price Movement - ( No change )
Prices as at 16:40, 27 May 2024
+Security prices are delayed by at least 20 minutes and are indicative only.

HLTH Related Research

Exchange Traded Fund Description

VanEck Global Healthcare Leaders ETF (HLTH) gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index.

VanEck Global Healthcare Leaders ETF (HLTH) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 11¢ 0% 3 Jul 2023 25 Jul 2023 $10.890 $11.020 -
HFResult 0% 1 Jul 2022 25 Jul 2022 $10.890 $11.020 -
HFResult 0% 1 Jul 2021 23 Jul 2021 $10.890 $11.020 -

See all dividends from VanEck Global Healthcare Leaders ETF (HLTH) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

VanEck Global Healthcare Leaders ETF (HLTH) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Issued Units Outstanding as at 30 April 2024 6 May 2024 5:21PM $10.850 $10.890 $11.020 risen by 0.37%
Issued Units Outstanding as at 31 March 2024 3 Apr 2024 8:27AM $11.430 $10.890 $11.020 fallen by 4.72%
Half-Year Financial Report 14 Mar 2024 3:21PM $11.290 $10.890 $11.020 fallen by 3.54%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from VanEck Global Healthcare Leaders ETF (HLTH) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

HLTH Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2023A $1.42 $22.20 -115.40% 46.90 11.00 1.10% 0.0%
2022A -$10.66 -$144.10 -241.80% 0.00 6.00 0.50% 0.0%
2021A $4.47 $101.60 0.00% 8.50 4.00 0.40% 0.0%

HLTH Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2021 A 2022 A 2023 A 2021 A 2022 A 2023 A 2021 A 2022 A 2023 A
VanEck Global Healthcare Leaders ETF (HLTH) $56M -1.1541 0.0000 0.0000 49.5045 0.0000 0.0000 1.00% 0.00% 0.00%
Magellan Financial Group (MFG) $1,516M -0.5164 -0.0458 -0.1145 8.3858 8.7881 9.9243 13.91% 6.75% 5.98%
Netwealth Group (NWL) $4,942M 0.1948 0.3656 0.1744 73.5294 53.8421 45.8456 1.19% 1.58% 1.85%
Pinnacle Investment Management Group (PNI) $2,651M -0.0127 -0.0682 0.2111 33.4615 35.9108 29.6524 2.76% 2.51% 2.70%
Perpetual (PPT) $2,498M -0.2217 0.0366 0.1016 13.1335 12.6699 11.5015 7.05% 5.91% 6.36%

HLTH Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 49.10 1.07 0.00
Market 0.48 14.40 1.09 1.02
Sector 0.46 12.60 1.03 0.91

HLTH Directors

Name Position Start Date
Mr Michael Brown Non-Executive Director 1 Jan 0001
Mr Bruce Smith Non-Executive Director 1 Jan 0001
Mr Jonathan Simon Non-Executive Director 1 Jan 0001
Mr Arian Neiron Non-Executive Director 1 Jan 0001
Mr Jan van Eck Non-Executive Director 1 Jan 0001

VanEck Global Healthcare Leaders ETF (HLTH) Changes in Directors' Interest & Trades

There are no directors' trades from VanEck Global Healthcare Leaders ETF (HLTH). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

HLTH Management

Name Position
Timothy Bethe Company Secretary,Head of Operations and Risk

FAQs about VanEck Global Healthcare Leaders ETF (HLTH)

VanEck Global Healthcare Leaders ETF's (HLTH) current share price is $10.89. This constitutes a price movement of 1.18% when compared to the share price 7 days ago and is -4.97% below HLTH's 12-month high of $11.46 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $10.89, VanEck Global Healthcare Leaders ETF's (HLTH) current share price of $10.89 constitutes a movement of or 0%. VanEck Global Healthcare Leaders ETF's (HLTH) share price movement is -1.18% when compared to 7 days ago and is -4.97% below HLTH's 52-week high of $11.46.

VanEck Global Healthcare Leaders ETF's (HLTH) 52-week high is $11.46 which was reached on 28 Mar 2024. Relative to this, HLTH's current share price of $10.89 constitutes a -$0.57 or -4.97% drop since that high of $11.46 per HLTH share.

VanEck Global Healthcare Leaders ETF's (HLTH) 52-week low is $9.48 which was reached on 31 Oct 2023. Relative to this, HLTH's current share price of $10.89 constitutes a $1.41 or 14.87% gain since that low of $9.48 per HLTH share.

VanEck Global Healthcare Leaders ETF's (HLTH) current market capitalisation is $55,587,951. Market capitalisation, sometimes referred to as "market cap", is the total value of a company's or ETF's issued shares or units owned by shareholders or unitholders. Market capitalisation is equal to the market price per share or unit multiplied by the number of shares or units outstanding.

VanEck Global Healthcare Leaders ETF (HLTH) last distribution or dividend was $0.11 per share and was paid on 25 Jul 2023. This last HLTH distribution or dividend included 0% franking.

Upcoming ex-distribution date: 3 Jul 2023

Upcoming record date: 4 Jul 2023

Upcoming payment date: 25 Jul 2023

ETFs, such as VanEck Global Healthcare Leaders ETF (HLTH), pay distributions instead of dividends. The difference is that dividends are declared by companies from part of the profits made during any given year and the company’s management decide the amount of earnings retained verses how much to pay out to investors. An ETF, like VanEck Global Healthcare Leaders ETF (HLTH), must pay out all realised income. This is a combination of any dividends received plus capital gains realised from the buying and selling of underlying holdings within VanEck Global Healthcare Leaders ETF (HLTH).


A distribution has three key dates:

Ex-distribution date: Date the distribution value leaves the ETF. This will normally correspond with the ETF unit price dropping in value by the same amount as the distribution.

Record date: Date someone must be on the unit registry to receive the distribution.

Payment date date: Date the distribution is paid to the unit holder.

VanEck Global Healthcare Leaders ETF (HLTH) has a current dividend yield of n/a this year. Last year's dividend yield was 1.10%. The dividend yield for HLTH is a ratio that tells you the percentage of VanEck Global Healthcare Leaders ETF (HLTH)'s share price that it pays out in dividends each year. The dividend yield is calculated by dividing the annual dividends by the current share price.

The "management expense ratio" (MER) for VanEck Global Healthcare Leaders ETF (HLTH) is 0.45%. This is the total expense for operating an ETF or managed fund like VanEck Global Healthcare Leaders ETF (HLTH). This includes management fees and other operating expenses which all come out of an investor's return.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.